GenScript
Genscript is the world’s leading biotech company providing life sciences services and products. With gene synthesis, peptide, protein, antibody and preclinical drug development service capabilities, we are internationally recognized as a leading biotech company specializing in fundamental life sciences research and early-phase drug discovery services. As of 2018, more than 30,000 peer-reviewed journal articles cited GenScript’s services and products, making GenScript the most frequently cited biotech company in the world.
Neoantigen Peptide Synthesis Service
GenScript’s Neoantigen Peptide Synthesis Service supports everything from functional screening of neoantigen candidates for TCR therapy to clinical stage vaccine immunogenicity testing.
Self-amplifying RNA Synthesis
GenScript is proud to be one of the first saRNA suppliers to offer tailored design and modifications with reliable quality to help speed up your innovative research projects.
GenCRISPR Synthetic sgRNA
Accelerate precision gene editing with GenScript's customized synthetic sgRNA, up to 200 nt in length.
TurboCHO™ Services (upgraded to 2.0 version starting at 5BDs)
TurboCHO™ Recombinant Protein Expression System
Genscript is the world’s leading biotech company providing life sciences services and products. With gene synthesis, peptide, protein, antibody and preclinical drug development service capabilities, we are internationally recognized as a leading biotech company specializing in fundamental life sciences research and early-phase drug discovery services. As of 2018, more than 30,000 peer-reviewed journal articles cited GenScript’s services and products, making GenScript the most frequently cited biotech company in the world.